Skip to main content
PMC home page
Archives of Disease in Childhood. Fetal and Neonatal Edition logoLink to Archives of Disease in Childhood. Fetal and Neonatal Edition
. 2003 Mar;88(2):F124–F127. doi: 10.1136/fn.88.2.F124

Progress in treatment and outcome for children with neonatal haemochromatosis

D Flynn, N Mohan, P McKiernan, S Beath, J Buckels, D Mayer, D Kelly
PMCID: PMC1721526  PMID: 12598501

Abstract

Aim: To evaluate the role of antioxidant treatment and liver transplantation in the management of neonatal haemochromatosis.

Methods: A retrospective review was performed of eight infants with acute liver failure and raised ferritin levels between 1990 and 1998. From 1994, treatment with an antioxidant cocktail (vitamin E, N-acetylcysteine, selenium, prostaglandin E1, and desferrioxamine) was begun once the diagnosis was suspected. Pathological and other findings were reviewed, and outcome before and after antioxidant treatment was evaluated.

Results: Median age at presentation was 4 days with median ferritin levels of 4180 µg/l (range 1650–40 000 µg/l; normal range 110–503 µg/l). Three infants presented before 1994. One infant died before liver transplantation from acute liver failure and one from neurological damage after transplantation. The third patient underwent successful transplantation at day 13 and remains well on follow up 8 years later. From 1994, five patients received antioxidant treatment, of whom two responded: both responders started antioxidants earlier (by day 5) than non-responders and had lower peak ferritin levels (< 4200 µg/l) and a milder phenotype. Treatment was continued until ferritin levels were < 500 µg/l. Both children remain well with mean follow up of 42 months, with no recurrence of iron overload. One child showed a partial response to treatment and survived long enough for a liver transplant, but died from graft failure after the transplant. Two children did not respond to antioxidant treatment; both had multiorgan failure and were not listed for transplantation. Only three of the eight patients survived (37.5%) over this time period.

Conclusion: Neonatal haemochromatosis can be a fatal disease with > 60% mortality. Early treatment with antioxidant cocktail is beneficial and may be curative in those who present with milder phenotype. Liver transplantation should always be considered at an early stage in non-responders and in children with more severe acute liver failure.

Full Text

The Full Text of this article is available as a PDF (108.6 KB).

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Colletti R. B., Clemmons J. J. Familial neonatal hemochromatosis with survival. J Pediatr Gastroenterol Nutr. 1988 Jan-Feb;7(1):39–45. doi: 10.1097/00005176-198801000-00009. [DOI] [PubMed] [Google Scholar]
  2. Edery P., Gérard B., Chretien D., Rötig A., Cerrone R., Rabier D., Rambaud C., Fabre M., Saudubray J. M., Munnich A. Liver cytochrome c oxidase deficiency in a case of neonatal-onset hepatic failure. Eur J Pediatr. 1994 Mar;153(3):190–194. doi: 10.1007/BF01958984. [DOI] [PubMed] [Google Scholar]
  3. Goncalves I., Hermans D., Chretien D., Rustin P., Munnich A., Saudubray J. M., Van Hoof F., Reding R., de Ville de Goyet J., Otte J. B. Mitochondrial respiratory chain defect: a new etiology for neonatal cholestasis and early liver insufficiency. J Hepatol. 1995 Sep;23(3):290–294. [PubMed] [Google Scholar]
  4. Hayes A. M., Jaramillo D., Levy H. L., Knisely A. S. Neonatal hemochromatosis: diagnosis with MR imaging. AJR Am J Roentgenol. 1992 Sep;159(3):623–625. doi: 10.2214/ajr.159.3.1503038. [DOI] [PubMed] [Google Scholar]
  5. Kelly A. L., Lunt P. W., Rodrigues F., Berry P. J., Flynn D. M., McKiernan P. J., Kelly D. A., Mieli-Vergani G., Cox T. M. Classification and genetic features of neonatal haemochromatosis: a study of 27 affected pedigrees and molecular analysis of genes implicated in iron metabolism. J Med Genet. 2001 Sep;38(9):599–610. doi: 10.1136/jmg.38.9.599. [DOI] [PMC free article] [PubMed] [Google Scholar]
  6. Kelly D. A. Current results and evolving indications for liver transplantation in children. J Pediatr Gastroenterol Nutr. 1998 Aug;27(2):214–221. doi: 10.1097/00005176-199808000-00017. [DOI] [PubMed] [Google Scholar]
  7. Knisely A. S., O'Shea P. A., Stocks J. F., Dimmick J. E. Oropharyngeal and upper respiratory tract mucosal-gland siderosis in neonatal hemochromatosis: an approach to biopsy diagnosis. J Pediatr. 1988 Nov;113(5):871–874. doi: 10.1016/s0022-3476(88)80022-2. [DOI] [PubMed] [Google Scholar]
  8. Krähenbühl S., Kleinle S., Henz S., Leibundgut K., Liechti S., Zimmermann A., Wiesmann U. Microvesicular steatosis, hemosiderosis and rapid development of liver cirrhosis in a patient with Pearson's syndrome. J Hepatol. 1999 Sep;31(3):550–555. doi: 10.1016/s0168-8278(99)80050-6. [DOI] [PubMed] [Google Scholar]
  9. Laxer R. M., Roberts E. A., Gross K. R., Britton J. R., Cutz E., Dimmick J., Petty R. E., Silverman E. D. Liver disease in neonatal lupus erythematosus. J Pediatr. 1990 Feb;116(2):238–242. doi: 10.1016/s0022-3476(05)82880-x. [DOI] [PubMed] [Google Scholar]
  10. Lee W. S., McKiernan P. J., Kelly D. A. Serum ferritin level in neonatal fulminant liver failure. Arch Dis Child Fetal Neonatal Ed. 2001 Nov;85(3):F226–F226. doi: 10.1136/fn.85.3.F225c. [DOI] [PMC free article] [PubMed] [Google Scholar]
  11. Lund D. P., Lillehei C. W., Kevy S., Perez-Atayde A., Maller E., Treacy S., Vacanti J. P. Liver transplantation in newborn liver failure: treatment for neonatal hemochromatosis. Transplant Proc. 1993 Feb;25(1 Pt 2):1068–1071. [PubMed] [Google Scholar]
  12. Martí-Bonmatí L., Baamonde A., Poyatos C. R., Monteagudo E. Prenatal diagnosis of idiopathic neonatal hemochromatosis with MRI. Abdom Imaging. 1994 Jan-Feb;19(1):55–56. doi: 10.1007/BF02165863. [DOI] [PubMed] [Google Scholar]
  13. Muiesan P., Rela M., Kane P., Dawan A., Baker A., Ball C., Mowat A. P., Williams R., Heaton N. D. Liver transplantation for neonatal haemochromatosis. Arch Dis Child Fetal Neonatal Ed. 1995 Nov;73(3):F178–F180. doi: 10.1136/fn.73.3.f178. [DOI] [PMC free article] [PubMed] [Google Scholar]
  14. Murray K. F., Kowdley K. V. Neonatal hemochromatosis. Pediatrics. 2001 Oct;108(4):960–964. doi: 10.1542/peds.108.4.960. [DOI] [PubMed] [Google Scholar]
  15. Müller-Berghaus J., Knisely A. S., Zaum R., Vierzig A., Kirn E., Michalk D. V., Roth B. Neonatal haemochromatosis: report of a patient with favourable outcome. Eur J Pediatr. 1997 Apr;156(4):296–298. doi: 10.1007/s004310050604. [DOI] [PubMed] [Google Scholar]
  16. Schoenlebe J., Buyon J. P., Zitelli B. J., Friedman D., Greco M. A., Knisely A. S. Neonatal hemochromatosis associated with maternal autoantibodies against Ro/SS-A and La/SS-B ribonucleoproteins. Am J Dis Child. 1993 Oct;147(10):1072–1075. doi: 10.1001/archpedi.1993.02160340058014. [DOI] [PubMed] [Google Scholar]
  17. Setchell K. D., Schwarz M., O'Connell N. C., Lund E. G., Davis D. L., Lathe R., Thompson H. R., Weslie Tyson R., Sokol R. J., Russell D. W. Identification of a new inborn error in bile acid synthesis: mutation of the oxysterol 7alpha-hydroxylase gene causes severe neonatal liver disease. J Clin Invest. 1998 Nov 1;102(9):1690–1703. doi: 10.1172/JCI2962. [DOI] [PMC free article] [PubMed] [Google Scholar]
  18. Shneider B. L., Setchell K. D., Whitington P. F., Neilson K. A., Suchy F. J. Delta 4-3-oxosteroid 5 beta-reductase deficiency causing neonatal liver failure and hemochromatosis. J Pediatr. 1994 Feb;124(2):234–238. doi: 10.1016/s0022-3476(94)70310-8. [DOI] [PubMed] [Google Scholar]
  19. Siafakas C. G., Jonas M. M., Perez-Atayde A. R. Abnormal bile acid metabolism and neonatal hemochromatosis: a subset with poor prognosis. J Pediatr Gastroenterol Nutr. 1997 Sep;25(3):321–326. doi: 10.1097/00005176-199709000-00015. [DOI] [PubMed] [Google Scholar]
  20. Sigurdsson L., Reyes J., Kocoshis S. A., Hansen T. W., Rosh J., Knisely A. S. Neonatal hemochromatosis: outcomes of pharmacologic and surgical therapies. J Pediatr Gastroenterol Nutr. 1998 Jan;26(1):85–89. doi: 10.1097/00005176-199801000-00015. [DOI] [PubMed] [Google Scholar]
  21. Sigurdsson L., Reyes J., Kocoshis S. A., Hansen T. W., Rosh J., Knisely A. S. Neonatal hemochromatosis: outcomes of pharmacologic and surgical therapies. J Pediatr Gastroenterol Nutr. 1998 Jan;26(1):85–89. doi: 10.1097/00005176-199801000-00015. [DOI] [PubMed] [Google Scholar]

Articles from Archives of Disease in Childhood Fetal and Neonatal Edition are provided here courtesy of BMJ Publishing Group

RESOURCES